{{Rsnum
|rsid=2787702
|Chromosome=10
|position=63307475
|Orientation=plus
|GMAF=0.393
|Assembly=GRCh37.p5
|GenomeBuild=37.3
|dbSNPBuild=137
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 38.1 | 51.3 | 10.6
| HCB | 14.6 | 46.7 | 38.7
| JPT | 15.0 | 51.3 | 33.6
| YRI | 54.1 | 38.4 | 7.5
| ASW | 42.1 | 50.9 | 7.0
| CHB | 14.6 | 46.7 | 38.7
| CHD | 20.2 | 40.4 | 39.4
| GIH | 29.7 | 44.6 | 25.7
| LWK | 64.5 | 32.7 | 2.7
| MEX | 58.6 | 29.3 | 12.1
| MKK | 54.5 | 43.6 | 1.9
| TSI | 41.2 | 47.1 | 11.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23006423
  |Trait=Response to taxane treatment (placlitaxel)
  |Title=Genetic association with overall survival of taxane-treated lung cancer patients - A genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study.
  |RiskAllele=
  |Pval=9E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}